Influenza Vaccine Market by Distribution Channel, Type, and Geography - Forecast and Analysis 2023-2027

Published: May 2023 Pages: 162 SKU: IRTNTR73298

Influenza Vaccine Market Analysis Report 2023-2027:

The influenza vaccine market is estimated to grow at a CAGR of 6.89% between 2022 and 2027. The market size is forecast to increase by USD 2,933.88 million. The growth of the market depends on several factors, including the increasing prevalence and incidence of influenza, the rising awareness about influenza vaccination, and the initiation of immunization programs and research activities.

This influenza vaccine market report extensively covers market segmentation by distribution channel (hospitals and pharmacies, government and institutional, and others), type (live attenuated influenza vaccines and recombinant influenza vaccines), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Influenza Vaccine Market During the Forecast Period?

To learn more about this report, View Report Sample

Influenza Vaccine Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing prevalence and incidence of influenza is notably driving the market growth, although factors such as difficulty in diagnosis may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Influenza Vaccine Market Driver

The increasing prevalence and incidence of influenza are notably driving the market growth. Influenza's incidence and prevalence have increased considerably among all age groups globally. According to data from the CDC, from October 1, 2019, to March 21, 2020, 39 to 56 million people in the US suffered from the flu caused by the influenza virus.

Moreover, this increasing incidence of influenza in the country raised the number of hospitalizations from 400,000 on October 1, 2019, to 730,000 on March 21, 2020. This factor is boosting the demand for influenza vaccines for the treatment of the disease. Hence, this factor is expected to boost the growth of the global influenza vaccine market during the forecast period.

Significant Influenza Vaccine Market Trends

The need for revaccination is one of the major trends in the market. Influenza, which is a life-threatening disease, can result in the hospitalization of patients and prove fatal if not clinically attended to. Hence, to prevent instead of cure, vaccination is the ideal method for the prevention of influenza. However, to get maximum protection, vaccination shots should be taken each year prior to the onset of the influenza season. The antigenic drift of influenza viruses over time and the decline in vaccine-specific antibodies drive the need for recurring doses.

Moreover, with every season of influenza infection being different, coupled with the varied reactions of the virus-causing infection in people, a vaccine shot is required every year to maintain immunity against the circulating virus. The CDC recommends the annual seasonal flu vaccine as ideal to reduce the risk of being affected by the seasonal flu. This trend is driving the sales of vaccine units, which, in turn, is driving the market growth.

Major Influenza Vaccine Market Challenge

The difficulty in diagnosis may impede market growth. An accurate diagnosis of influenza is crucial for ensuring effective prevention and treatment, as well as for assessing the right strain to include in vaccines. However, diagnosing influenza can be challenging as the disease shares common symptoms with other respiratory infections, including the common cold or respiratory syncytial virus (RSV). In multiple respiratory diseases, symptoms may include fever, cough, sore throat, and fatigue. This poses a challenge to differentiate influenza from other conditions based solely on clinical symptoms.

Besides, influenza diagnostic tests are most accurate when conducted within a few days of the onset of symptoms. However, individuals often seek medical attention after the first few days of illness. As a result, the viral load may have already decreased, which affects the reliability of test results. Delayed testing can lead to false negatives, thereby leading to an underestimation of influenza cases. Hence, this factor may hinder the growth of the market during the forecast period.

Key Influenza Vaccine Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Influenza Vaccine Market Customer Landscape

Who are the Major Influenza Vaccine Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Altimmune Inc. - The company offers influenza vaccines such as NasoVax.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:

  • AstraZeneca PLC
  • Baxter International Inc.
  • BioDiem Ltd
  • BiondVax Pharmaceuticals Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • F. Hoffmann La Roche Ltd.
  • FluGen Inc.
  • GlaxoSmithKline Plc
  • Mitsubishi Chemical Group Corp.
  • Novavax Inc.
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Shijiazhuang Yiling Pharmaceutical Co Ltd.
  • SK Chemicals Co. Ltd.
  • Vaccitech Plc
  • Vaxart Inc.
  • Vaxine Pty Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segments in the Influenza Vaccine Market?

The market share growth by the hospitals and pharmacies segment will be significant during the forecast period. Hospitals play a key role in distributing influenza vaccines. They are responsible for administering vaccines, especially those patients at a high risk of contracting the flu. For instance, the elderly and individuals with underlying medical conditions. They may also purchase vaccines directly from manufacturers to distribute them to other healthcare facilities and pharmacies.

Get a glance at the market contribution of various segments View the PDF Sample

The hospital and pharmacies segment was valued at USD 2,771.78 million in 2017 and continued to grow until 2021.  Pharmacies also play a key role in distributing influenza vaccines. They offer convenient access to vaccines, making it easier for the general population to get vaccinated. Pharmacies may purchase vaccines from manufacturers or distributors and they either administer them on-site or provide them to other healthcare providers. To ensure access to vaccines for individuals and ensure their protection from the flu, the distribution of influenza vaccines through hospitals and pharmacies is essential. It also ensures the efficient and effective distribution of vaccines to those with the utmost need, which will drive the segment in the forecast period.

Which are the Key Regions for the Influenza Vaccine Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 54% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The region is expected to continue its dominance in the global influenza vaccine market throughout the forecast period. This can be attributed to the presence of government bodies in the region such as the Pan American Health Organization (PAHO), which recommend immunization schedules for vaccination. BOOSTRIX, INFANRIX, Pediarix, BEXSERO, MENVEO, and influenza are some of the major vaccines sold in the region.

In the past few years, the region has been witnessing the significant prevalence of several infectious diseases, including influenza, in developed countries. As a result, the region is witnessing increasing access to vaccines against such diseases, coupled with a rising number of initiatives to generate awareness around immunization programs. Hence, these factors are expected to boost the growth of the influenza vaccine market in North America during the forecast period.

In 2020, North American countries were severely affected by the outbreak of COVID-19. The increase in the incidence of COVID-19 across the region boosted the demand for influenza vaccines from end-user facilities to minimize the hospitalization of COVID-19 patients. Besides, the majority of the pharmaceutical companies enhanced their emphasis on developing and manufacturing influenza vaccines. All these factors positively impacted the growth of the influenza vaccine market in North America, especially in 2020. During the forecast period, the regional market is expected to witness positive growth. This can be attributed to factors such as the increasing focus of manufacturers on developing new dosages of influenza vaccine to ensure better protection and meet the high demand for influenza vaccines.

Segment Overview

The influenza vaccine market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Distribution Channel Outlook (USD Million, 2017 - 2027)
    • Hospitals and pharmacies
    • Government and institutional
    • Others
  • Type Outlook (USD Million, 2017 - 2027)
    • Live attenuated influenza vaccines
    • Recombinant influenza vaccines
  • Geography Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Brazil

Parent Market Analysis

Technavio categorizes the influenza vaccine market as a part of the global pharmaceuticals market, which covers products and companies engaged in the R&D or production of generic drugs, non-generic drugs, and veterinary drugs. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

 

Influenza Vaccine Market Scope

Report Coverage

Details

Page number

162

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.89%

Market growth 2023-2027

USD 2,933.88 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.67

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 54%

Key countries

US, Canada, UK, China, and India

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Altimmune Inc., AstraZeneca PLC, Baxter International Inc., BioDiem Ltd, BiondVax Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., FluGen Inc., GlaxoSmithKline Plc, Mitsubishi Chemical Group Corp., Novavax Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Shijiazhuang Yiling Pharmaceutical Co Ltd., SK Chemicals Co. Ltd., Vaccitech Plc, Vaxart Inc., and Vaxine Pty Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Influenza Vaccine Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the market and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global influenza vaccine market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global influenza vaccine market 2017 - 2021 ($ million)
    • 4.2 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
    • 4.3 Type Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 32: Chart on Comparison by Distribution Channel
      • Exhibit 33: Data Table on Comparison by Distribution Channel
    • 6.3 Hospitals and pharmacies - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
    • 6.4 Government and institutional - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Government and institutional - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Government and institutional - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Government and institutional - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Government and institutional - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Distribution Channel
      • Exhibit 46: Market opportunity by Distribution Channel ($ million)
      • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 Live attenuated influenza vaccines - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
    • 7.4 Recombinant influenza vaccines - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 60: Market opportunity by Type ($ million)
      • Exhibit 61: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 India - Market size and forecast 2022-2027
      • Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Altimmune Inc.
              • Exhibit 111: Altimmune Inc. - Overview
              • Exhibit 112: Altimmune Inc. - Product / Service
              • Exhibit 113: Altimmune Inc. - Key news
              • Exhibit 114: Altimmune Inc. - Key offerings
            • 12.4 AstraZeneca PLC
              • Exhibit 115: AstraZeneca PLC - Overview
              • Exhibit 116: AstraZeneca PLC - Product / Service
              • Exhibit 117: AstraZeneca PLC - Key news
              • Exhibit 118: AstraZeneca PLC - Key offerings
            • 12.5 Baxter International Inc.
              • Exhibit 119: Baxter International Inc. - Overview
              • Exhibit 120: Baxter International Inc. - Business segments
              • Exhibit 121: Baxter International Inc. - Key news
              • Exhibit 122: Baxter International Inc. - Key offerings
              • Exhibit 123: Baxter International Inc. - Segment focus
            • 12.6 BiondVax Pharmaceuticals Ltd.
              • Exhibit 124: BiondVax Pharmaceuticals Ltd. - Overview
              • Exhibit 125: BiondVax Pharmaceuticals Ltd. - Product / Service
              • Exhibit 126: BiondVax Pharmaceuticals Ltd. - Key offerings
            • 12.7 CSL Ltd.
              • Exhibit 127: CSL Ltd. - Overview
              • Exhibit 128: CSL Ltd. - Business segments
              • Exhibit 129: CSL Ltd. - Key news
              • Exhibit 130: CSL Ltd. - Key offerings
              • Exhibit 131: CSL Ltd. - Segment focus
            • 12.8 FluGen Inc.
              • Exhibit 132: FluGen Inc. - Overview
              • Exhibit 133: FluGen Inc. - Product / Service
              • Exhibit 134: FluGen Inc. - Key offerings
            • 12.9 GlaxoSmithKline Plc
              • Exhibit 135: GlaxoSmithKline Plc - Overview
              • Exhibit 136: GlaxoSmithKline Plc - Business segments
              • Exhibit 137: GlaxoSmithKline Plc - Key news
              • Exhibit 138: GlaxoSmithKline Plc - Key offerings
              • Exhibit 139: GlaxoSmithKline Plc - Segment focus
            • 12.10 Mitsubishi Chemical Group Corp.
              • Exhibit 140: Mitsubishi Chemical Group Corp. - Overview
              • Exhibit 141: Mitsubishi Chemical Group Corp. - Business segments
              • Exhibit 142: Mitsubishi Chemical Group Corp. - Key offerings
              • Exhibit 143: Mitsubishi Chemical Group Corp. - Segment focus
            • 12.11 Novavax Inc.
              • Exhibit 144: Novavax Inc. - Overview
              • Exhibit 145: Novavax Inc. - Product / Service
              • Exhibit 146: Novavax Inc. - Key offerings
            • 12.12 Pfizer Inc.
              • Exhibit 147: Pfizer Inc. - Overview
              • Exhibit 148: Pfizer Inc. - Product / Service
              • Exhibit 149: Pfizer Inc. - Key news
              • Exhibit 150: Pfizer Inc. - Key offerings
            • 12.13 Sanofi SA
              • Exhibit 151: Sanofi SA - Overview
              • Exhibit 152: Sanofi SA - Business segments
              • Exhibit 153: Sanofi SA - Key news
              • Exhibit 154: Sanofi SA - Key offerings
              • Exhibit 155: Sanofi SA - Segment focus
            • 12.14 Shijiazhuang Yiling Pharmaceutical Co Ltd.
              • Exhibit 156: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
              • Exhibit 157: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
              • Exhibit 158: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
            • 12.15 SK Chemicals Co. Ltd.
              • Exhibit 159: SK Chemicals Co. Ltd. - Overview
              • Exhibit 160: SK Chemicals Co. Ltd. - Business segments
              • Exhibit 161: SK Chemicals Co. Ltd. - Key offerings
              • Exhibit 162: SK Chemicals Co. Ltd. - Segment focus
            • 12.16 Vaccitech Plc
              • Exhibit 163: Vaccitech Plc - Overview
              • Exhibit 164: Vaccitech Plc - Product / Service
              • Exhibit 165: Vaccitech Plc - Key offerings
            • 12.17 Vaxart Inc.
              • Exhibit 166: Vaxart Inc. - Overview
              • Exhibit 167: Vaxart Inc. - Product / Service
              • Exhibit 168: Vaxart Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 169: Inclusions checklist
                • Exhibit 170: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 171: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 172: Research methodology
                • Exhibit 173: Validation techniques employed for market sizing
                • Exhibit 174: Information sources
              • 13.5 List of abbreviations
                • Exhibit 175: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              influenza vaccine market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis